Robert Thomas Mccormack
44 works · 4,083 citations · h-index 21
Top works
- Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
- Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
- Considerations in the development of circulating tumor cell technology for clinical use
- Cardiac troponin I measurement with the ACCESS® immunoassay system: analytical and clinical performance characteristics
- Breaking a Vicious Cycle
- Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.
- Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components
- Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
- Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer
- Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism
- Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate Cancer
- Structure/function studies of the common acute lymphoblastic leukemia antigen (CALLA/CD10) expressed on human neutrophils.
- Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
- Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
- Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
- Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide
- Early assessment of circulating tumor cell results in a community-based practice
- Decreased expression of the common acute lymphoblastic leukaemia antigen (CALLA/CD10) on neutrophils from patients with thermal injury
- International liquid biopsy standardization alliance white paper
- Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized double-blind, placebo-controlled phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel.